Article
Candidate-gene-based study of CYP3A-related single-nucleotide polymorphisms using 4β-hydroxycholesterol/cholesterol ratio as biomarker in a Japanese cohort.
European journal of clinical pharmacology - 19 Jun 2026
Tanaka Ryota, Suzuki Yosuke, Koyama Teruhide, Sumimoto Takahiro, Oda Ayako, Sato Haruki, Ozaki Etsuko, Tatsuta Ryosuke, Yamamoto Yasuyuki, Nakatochi Masahiro, Momozawa Yukihide, Ohno Keiko, Takashima Naoyuki, Matsuo Keitaro, Itoh Hiroki
Abstract excerpt
PURPOSE: CYP3A4 and CYP3A5 are major drug‑metabolizing enzymes that require electrons supplied by P450 oxidoreductase (POR) for catalytic cycle. CYP3A expression is regulated by the nuclear receptors; constitutive androstane receptor (CAR) and pregnane X receptor (PXR). Single-nucleotide polymorphisms (SNPs) of CYP3A5, CYP3A4, POR, CAR, and PXR have been documented to modulate CYP3A enzyme activity and/or...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
